CRISPR Therapeutics AG (CRSP) Revenue (2016 - 2026)
CRISPR Therapeutics AG (CRSP) reported Revenue of $1.5 million for Q1 2026, up 68.55% on a YoY basis from $865000.0 in Q1 2025, and up 68.75% sequentially from $864000.0 in Q4 2025.
CRISPR Therapeutics AG (CRSP) Revenue (2016 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 11 years of Revenue data on file, last reported at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 68.55% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (down 89.11% YoY), and the FY2025 full-year result was $3.5 million, down 90.59% from the prior year.
- Revenue rose to $1.5 million in Q1 2026, from $864000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $201.2 million in Q4 2023 to a low of $6000.0 in Q4 2022.
- A 5-year average of $25.9 million and a median of $877000.0 in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue tumbled 99.98% in 2022 and soared 3353333.33% in 2023, its largest moves.
- Tracing CRSP's Revenue over 5 years: stood at $6000.0 in 2022, then soared by 3353333.33% to $201.2 million in 2023, then tumbled by 82.26% to $35.7 million in 2024, then plunged by 97.58% to $864000.0 in 2025, then jumped by 68.75% to $1.5 million in 2026.
- Business Quant data shows CRSP's Revenue at $1.5 million in Q1 2026, $864000.0 in Q4 2025, and $889000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.47 Bn | 2.03 Bn | - | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 864,000.00 |
| Sep 30, 2025 | 889,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 35.69 Mn |
| Sep 30, 2024 | 602,000.00 |
| Jun 30, 2024 | 517,000.00 |
| Mar 31, 2024 | 504,000.00 |
| Dec 31, 2023 | 201.21 Mn |
| Jun 30, 2023 | 70.00 Mn |
| Mar 31, 2023 | 100.00 Mn |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 94,000.00 |
| Jun 30, 2022 | 158,000.00 |
| Mar 31, 2022 | 940,000.00 |
| Dec 31, 2021 | 12.90 Mn |
| Sep 30, 2021 | 824,000.00 |
| Jun 30, 2021 | 900.70 Mn |
| Mar 31, 2021 | 539,000.00 |